quinelorane has been researched along with dihydrexidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doll, MK; Kilts, JD; Lawler, CP; Lewis, MM; Mailman, RB; Nichols, DE; Prioleau, C | 1 |
| Goulet, M; Madras, BK | 1 |
2 other study(ies) available for quinelorane and dihydrexidine
| Article | Year |
|---|---|
Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane.
Topics: Animals; Binding, Competitive; Dopamine Agonists; In Vitro Techniques; Isoquinolines; Male; Naphthols; Neostriatum; Quinolines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Structure-Activity Relationship | 1999 |
D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Benzazepines; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Macaca fascicularis; Male; Motor Activity; Motor Skills; Oxazines; Parkinsonian Disorders; Phenanthridines; Quinolines; Receptors, Dopamine D1 | 2000 |